Zobrazeno 1 - 10
of 776
pro vyhledávání: '"M, Nadler"'
Autor:
Emma M. Siritzky, Patrick H. Cox, Sydni M. Nadler, Justin N. Grady, Dwight J. Kravitz, Stephen R. Mitroff
Publikováno v:
Cognitive Research, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract Standard cognitive psychology research practices can introduce inadvertent sampling biases that reduce the reliability and generalizability of the findings. Researchers commonly acknowledge and understand that any given study sample is not p
Externí odkaz:
https://doaj.org/article/a6adc07e9e864cafb1b68407958642b4
Autor:
Anthony M Nadler
The professional judgment of gatekeepers defined the American news agenda for decades. Making the News Popular examines how subsequent events brought on a post-professional period that opened the door for imagining that consumer preferences should dr
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract PARP inhibitors (PARPi) have modest antitumor activity in patients with advanced breast cancer and mutation in BRCA. It is unclear whether some subgroups derive greater benefit from treatment. MEDLINE and EMBASE were searched from inception
Externí odkaz:
https://doaj.org/article/d3d706c2421047dc86bf84b328cad73f
Autor:
Elaine H. Morrato, Lindsay A. Lennox, Elaina R. Sendro, Anne L. Schuster, Harold A. Pincus, Jennifer Humensky, Gary S. Firestein, Lee M. Nadler, Robert Toto, Steven E. Reis
Publikováno v:
Journal of Clinical and Translational Science, Vol 4, Pp 515-528 (2020)
Abstract Introduction: The Clinical and Translational Science Award (CTSA) Program is a Consortium of nearly 60 academic medical research centers across the USA and a natural network for evaluating the spread and uptake of translational research inn
Externí odkaz:
https://doaj.org/article/48d1008d85e44bb3b4d0c85a582c4181
Autor:
Lee M. Nadler, Robert L. Coffman, George Demetri, Patrick Wen, Jeffrey Morgan, Jeffrey Kutok, Xiaochun Li, Donna Neuberg, Paul Sims, Suzanne George, Kate Russell, Steven Rivoli, Jill Angelosanto, John Evans, Thomas Brenn, Linda Drury, Holger Kanzler, Jeffrey Davies, W. Nicholas Haining
Supplementary Data from CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9a9e677a7e9db4aaa9e8a531e30862
https://doi.org/10.1158/1078-0432.22439638.v1
https://doi.org/10.1158/1078-0432.22439638.v1
Autor:
Lee M. Nadler, Robert L. Coffman, George Demetri, Patrick Wen, Jeffrey Morgan, Jeffrey Kutok, Xiaochun Li, Donna Neuberg, Paul Sims, Suzanne George, Kate Russell, Steven Rivoli, Jill Angelosanto, John Evans, Thomas Brenn, Linda Drury, Holger Kanzler, Jeffrey Davies, W. Nicholas Haining
Purpose: CpG oligodeoxynucleotides (CpG-ODN) are being investigated as cancer vaccine adjuvants because they mature plasmacytoid dendritic cells (PDC) into potent antigen-presenting cells. CpG-ODN also induce PDC to secrete chemokines that alter lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d711fbde563e84f3fee23c9e76d03378
https://doi.org/10.1158/1078-0432.c.6517075.v1
https://doi.org/10.1158/1078-0432.c.6517075.v1
Autor:
Eva C. Guinan, Lee M. Nadler, Richard E. Champlin, Peter F. Thall, Laurence J. Cooper, Marcos de Lima, Thomas R. Spitzer, Bimalangshu R. Dey, Ami J. Shah, Neena Kapoor, Christopher R. Cogle, John R. Wingard, Lisa L. Brennan, Jeff K. Davies
Purpose: Allogeneic hematopoietic stem-cell transplantation (HSCT) is a curative treatment for many hematologic cancers. Use of haploidentical (mismatched) donors increases HSCT availability but is limited by severe graft-versus-host disease (GvHD) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4657df4073dbc61e5035bb4eacd58ef8
https://doi.org/10.1158/1078-0432.c.6527625
https://doi.org/10.1158/1078-0432.c.6527625
Autor:
Eva C. Guinan, Lee M. Nadler, Richard E. Champlin, Peter F. Thall, Laurence J. Cooper, Marcos de Lima, Thomas R. Spitzer, Bimalangshu R. Dey, Ami J. Shah, Neena Kapoor, Christopher R. Cogle, John R. Wingard, Lisa L. Brennan, Jeff K. Davies
Table S1 Patients, donors, HLA-mismatches and conditioning; Table S2 Cell doses in stem cell transplant, engraftment and chimerism; Table S3 ADLI dose and timing and allostimulator source; Table S4 Patient outcomes; Figure S1 Schema for clinical stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a511c5315fc2fb51fb247093d838fa2
https://doi.org/10.1158/1078-0432.22470588
https://doi.org/10.1158/1078-0432.22470588